Biomaxima (WAR:BMX) Margin of Safety % (DCF FCF Based): N/A (As of Jul. 21, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

WAR:BMX Biomaxima SA WAR:BMX
51 GF Score
Price zł9.77
GF Value zł15.43
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Biomaxima Margin of Safety % (DCF FCF Based)?

Margin of Safety % (DCF FCF Based) = (Intrinsic Value: DCF (FCF Based) - Current Price) / Intrinsic Value: DCF (FCF Based).

Note: Discounted FCF model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Biomaxima's Predictability Rank is 1-Star. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF FCF Based) is not calculated.

WAR:BMX vs TMO, DHR, IDXX: Margin of Safety % (DCF FCF Based) Comparison

For the Diagnostics & Research subindustry, Biomaxima's Margin of Safety % (DCF FCF Based), along with its competitors' market caps and Margin of Safety % (DCF FCF Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Biomaxima Margin of Safety % (DCF FCF Based) vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Biomaxima's Margin of Safety % (DCF FCF Based) distribution charts can be found below:

* The bar in red indicates where Biomaxima's Margin of Safety % (DCF FCF Based) falls into.


WAR:BMX
51GF Score
Biomaxima SA WAR:BMX
Margin of Safety % (DCF FCF Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Biomaxima (WAR:BMX) Overvalued in 2026?

Based on GuruFocus' analysis, Biomaxima stock appears to be undervalued. The current stock price of zł9.77 is trading 36.7% below its estimated GF Value™ of zł15.43. GuruFocus considers Biomaxima to be Possible Value Trap.

Key valuation signals for WAR:BMX:

  • Margin of Safety % (DCF FCF Based): N/A
  • GF Value™: zł15.43 vs. price of zł9.77 (36.7% below fair value)
  • GF Score™: 51/100 with 4 warning signs

No single metric tells the full story. See the WAR:BMX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Biomaxima Business Description

Address 5 Vetterow Street, Lublin, POL, 20-277
BioMaxima SA is a Polish company operating in the market of laboratory diagnostics. It is a manufacturer of microbiological substrates as well as a wide range of reagents and diagnostic equipment. The company is also a distributor of products of recognized multinational diagnostic companies such as: Accelerate Diagnostics, Nova Biomedical, PHC Group, Technoclone, Kabe and Biolog.
51GF Score

Get the complete analysis for WAR:BMX

Margin of Safety % (DCF FCF Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

zł9.77
Price
zł15.43
GF Value